Taken together, a broad spectrum of neurological manifestations including coexisting MS may occur in patients with low-penetrance variants of the TNFRSF1A-, NLRP3-, and MEFV genes and both neurologists and rheumatologists should keep this in mind. Here, NLRP3 is linked to myeloid sarcoma.